Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis

Journal of Parenteral and Enteral Nutrition

Volumn 21, Issue 2, 1997, Pages 100-103

  Teitelbaum, Daniel H ^a,b   Han Markey, Theresa ^a   Drongowski, Robert A ^a   Coran, Arnold G ^a   Bayar, Bilge ^a   Geiger, James D ^a   Uitvlugt, Neal ^a   Schork, M Anthony ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN GLUCURONIDE; CHOLECYSTOKININ OCTAPEPTIDE;

ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; PRIORITY JOURNAL; PROPHYLAXIS; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME;

EID: 0031003226     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607197021002100     Document Type: Article

References (17)

1. Merritt R: Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr 5:9-22, 1986
2. Drongowski RA, Coran AG: An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis. JPEN 13:586-589, 1989
3. Bell R, Ferry G, Smith E: Total parenteral nutrition-associated cholestasis in infants. JPEN 10:356-359, 1986
4. Magnusson I, Thulin L, Einarsson K: Effects of substance P and somatostatin on taurocholate-stabilized and CCK-or secretin-induced choleresis in the anesthetized dog. Scand J Gastroenterol 19:1007-1014, 1984.
5. Magnusson I, Thulin L: Effect of substance P on CCK-or VIP-induced choleresis in anesthetized dogs. Acta Physiol Scand 106:293-297,1979
6. Kaminski DL, Rose RC, Nahrwold DL: Effect of pentagastrin on cholecystokinin and secretin choleresis in the dog. J Surg Res 17:26-29, 1974
7. Rintala RJ, Lindahl H, Pohjavuori M: Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholecystokinin: A preliminary report. J Pediatr Surg 30:827-830, 1995
8. Teitelbaum DH, Han-Markey T, Schumacher RE: Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide. J Pediatr Surg 30:1082-1085, 1995
9. Sandler R, Kleinman R: IN Pediatric Gastrointestinal Disease, Walker W, Durie P, Hamilton J, et al (eds). BC Decker, Inc, Philadelphia, 1991, pp 1065-1071
10. Teitelbaum D, Drongowski R, Spivak D: Rapid development of hyperbilirubinemia in infants with the short bowel syndrome as a correlate to mortality: Possible indication for early small bowel transplantation. Transplant Proc 28:2677-2678, 1996
11. Ginn-Pease M, Pantalos D, King D: TPN-associated hyperbilirubinemia: A common problem in newborn surgical patients. J Pediatr Surg 20:436-439, 1985
12. Touloukian R, Seashore J: Hepatic secretory obstruction with total parenteral nutrition in the infant. J Pediatr Surg 10:353-360, 1975
13. Sitzman J, Pitt H, Steinborn P, et al: Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet 170:25-31, 1990
14. Teitelbaum D, O'Dorisio T, Gaginella T, et al: Effects of Caerulein on rat small and large intestinal fluid transport, in vivo. Reg Peptide 4:97-105, 1982
15. Beath S, Davies P, Papadpoulou A, et al: Parenteral nutrition-related cholestasis in postsurgical neonates: Multivariate analysis of risk factors. J Pediatr Surg 31:604-606, 1996
16. Innis S: Effect of cholecystokinin-octapeptide on total parenteral nutrition-induced changes in hepatic bile secretion and composition in the rat. J Pediatr Gastroenterol Nutr 5:793-798, 1986
17. Curran TJ, Uzoaru I, Das JB, et al: The effect of cholecystokinin-octapeptide on the hepatobiliary dysfunction caused by total parenteral nutrition. J Pediatr Surg 30:242-246, 1995